389 related articles for article (PubMed ID: 24877061)
1. Inflammation based regulation of cancer cachexia.
Onesti JK; Guttridge DC
Biomed Res Int; 2014; 2014():168407. PubMed ID: 24877061
[TBL] [Abstract][Full Text] [Related]
2. Exercise as an anti-inflammatory therapy for cancer cachexia: a focus on interleukin-6 regulation.
Daou HN
Am J Physiol Regul Integr Comp Physiol; 2020 Feb; 318(2):R296-R310. PubMed ID: 31823669
[TBL] [Abstract][Full Text] [Related]
3. Endoplasmic Reticulum Stress, Calcium Dysregulation and Altered Protein Translation: Intersection of Processes That Contribute to Cancer Cachexia Induced Skeletal Muscle Wasting.
Isaac ST; Tan TC; Polly P
Curr Drug Targets; 2016; 17(10):1140-6. PubMed ID: 25882219
[TBL] [Abstract][Full Text] [Related]
4. Combined effect of aerobic interval training and selenium nanoparticles on expression of IL-15 and IL-10/TNF-α ratio in skeletal muscle of 4T1 breast cancer mice with cachexia.
Molanouri Shamsi M; Chekachak S; Soudi S; Quinn LS; Ranjbar K; Chenari J; Yazdi MH; Mahdavi M
Cytokine; 2017 Feb; 90():100-108. PubMed ID: 27863332
[TBL] [Abstract][Full Text] [Related]
5. Selumetinib Attenuates Skeletal Muscle Wasting in Murine Cachexia Model through ERK Inhibition and AKT Activation.
Quan-Jun Y; Yan H; Yong-Long H; Li-Li W; Jie L; Jin-Lu H; Jin L; Peng-Guo C; Run G; Cheng G
Mol Cancer Ther; 2017 Feb; 16(2):334-343. PubMed ID: 27599525
[TBL] [Abstract][Full Text] [Related]
6. [Systemic and local mechanisms leading to cachexia in cancer].
Grabiec K; Burchert M; Milewska M; Błaszczyk M; Grzelkowska-Kowalczyk K
Postepy Hig Med Dosw (Online); 2013 Dec; 67():1397-409. PubMed ID: 24493689
[TBL] [Abstract][Full Text] [Related]
7. The biological mechanisms of cancer-related skeletal muscle wasting: the role of progressive resistance exercise.
Al-Majid S; Waters H
Biol Res Nurs; 2008 Jul; 10(1):7-20. PubMed ID: 18705151
[TBL] [Abstract][Full Text] [Related]
8. Pantoprazole blocks the JAK2/STAT3 pathway to alleviate skeletal muscle wasting in cancer cachexia by inhibiting inflammatory response.
Guo D; Wang C; Wang Q; Qiao Z; Tang H
Oncotarget; 2017 Jun; 8(24):39640-39648. PubMed ID: 28489606
[TBL] [Abstract][Full Text] [Related]
9. STAT3 in the systemic inflammation of cancer cachexia.
Zimmers TA; Fishel ML; Bonetto A
Semin Cell Dev Biol; 2016 Jun; 54():28-41. PubMed ID: 26860754
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms to explain wasting of muscle and fat in cancer cachexia.
Argilés JM; López-Soriano FJ; Busquets S
Curr Opin Support Palliat Care; 2007 Dec; 1(4):293-8. PubMed ID: 18685378
[TBL] [Abstract][Full Text] [Related]
11. Skeletal muscle is enriched in hematopoietic stem cells and not inflammatory cells in cachectic mice.
Berardi E; Aulino P; Murfuni I; Toschi A; Padula F; Scicchitano BM; Coletti D; Adamo S
Neurol Res; 2008 Mar; 30(2):160-9. PubMed ID: 18397608
[TBL] [Abstract][Full Text] [Related]
12. Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance.
Tuomisto AE; Mäkinen MJ; Väyrynen JP
World J Gastroenterol; 2019 Aug; 25(31):4383-4404. PubMed ID: 31496619
[TBL] [Abstract][Full Text] [Related]
13. Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate.
Mantovani G; Macciò A; Lai P; Massa E; Ghiani M; Santona MC
Semin Oncol; 1998 Apr; 25(2 Suppl 6):45-52. PubMed ID: 9625383
[TBL] [Abstract][Full Text] [Related]
14. Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia.
Shukla SK; Markov SD; Attri KS; Vernucci E; King RJ; Dasgupta A; Grandgenett PM; Hollingsworth MA; Singh PK; Yu F; Mehla K
Cancer Lett; 2020 Aug; 484():29-39. PubMed ID: 32344015
[TBL] [Abstract][Full Text] [Related]
15. Myofiber degeneration/regeneration is induced in the cachectic ApcMin/+ mouse.
Mehl KA; Davis JM; Berger FG; Carson JA
J Appl Physiol (1985); 2005 Dec; 99(6):2379-87. PubMed ID: 16288100
[TBL] [Abstract][Full Text] [Related]
16. Cancer cachexia: molecular targets and pathways for diagnosis and drug intervention.
Shum AM; Polly P
Endocr Metab Immune Disord Drug Targets; 2012 Sep; 12(3):247-59. PubMed ID: 22385113
[TBL] [Abstract][Full Text] [Related]
17. Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.
Siddiqui JA; Pothuraju R; Jain M; Batra SK; Nasser MW
Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188359. PubMed ID: 32222610
[TBL] [Abstract][Full Text] [Related]
18. STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia.
Bonetto A; Aydogdu T; Kunzevitzky N; Guttridge DC; Khuri S; Koniaris LG; Zimmers TA
PLoS One; 2011; 6(7):e22538. PubMed ID: 21799891
[TBL] [Abstract][Full Text] [Related]
19. Decreased Jun-D and myogenin expression in muscle wasting of human cachexia.
Ramamoorthy S; Donohue M; Buck M
Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E392-401. PubMed ID: 19470832
[TBL] [Abstract][Full Text] [Related]
20. MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.
Judge SM; Deyhle MR; Neyroud D; Nosacka RL; D'Lugos AC; Cameron ME; Vohra RS; Smuder AJ; Roberts BM; Callaway CS; Underwood PW; Chrzanowski SM; Batra A; Murphy ME; Heaven JD; Walter GA; Trevino JG; Judge AR
Cancer Res; 2020 May; 80(9):1861-1874. PubMed ID: 32132110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
